FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
-0.86%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$1.14B
AUM Growth
+$1.14B
(-13%)
Cap. Flow
-$99.7M
Cap. Flow
% of AUM
-8.74%
Top 10 Holdings %
Top 10 Hldgs %
42.55%
Holding
55
New
5
Increased
22
Reduced
16
Closed
11
Top Buys
| 1 |
LivaNova
LIVN
|
$33.3M |
| 2 |
FNA
Paragon 28, Inc.
FNA
|
$29.9M |
| 3 |
Evolent Health
EVH
|
$22.1M |
| 4 |
Vera Therapeutics
VERA
|
$20.6M |
| 5 |
Health Catalyst
HCAT
|
$20.6M |
Top Sells
| 1 |
Transmedics
TMDX
|
$61.9M |
| 2 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$52.6M |
| 3 |
iRhythm Technologies
IRTC
|
$48.8M |
| 4 |
Natera
NTRA
|
$31.1M |
| 5 |
MODN
MODEL N, INC.
MODN
|
$25.5M |
Sector Composition
| 1 | Healthcare | 97.29% |
| 2 | Industrials | 2.71% |
| 3 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNA
1
DELISTED
Paragon 28, Inc.
FNA
| $55.9M | 4.9% | 8,174,832 +4,371,864 | +115% | +$29.9M |
|
2
Alphatec Holdings
ATEC
$2.35B
| $55.7M | 4.88% | 5,327,978 -90,653 | -2% | -$947K |
|
3
Crinetics Pharmaceuticals
CRNX
$2.92B
| $53.8M | 4.71% | 1,200,508 -489,669 | -29% | -$21.9M |
|
4
NeoGenomics
NEO
$1.13B
| $52.5M | 4.6% | 3,782,561 +480,396 | +15% | +$6.66M |
|
5
Xenon Pharmaceuticals
XENE
$2.98B
| $50.9M | 4.46% | 1,306,260 -13,912 | -1% | -$542K |
|
|
6
Transmedics
TMDX
$3.92B
| $45.3M | 3.97% | 300,600 -411,082 | -58% | -$61.9M |
|
7
AtriCure
ATRC
$1.84B
| $44.7M | 3.92% | 1,964,703 +581,843 | +42% | +$13.2M |
|
8
Insulet
PODD
$23.9B
| $43.5M | 3.81% | 215,637 +64,373 | +43% | +$13M |
|
|
CNTA
9
Centessa Pharmaceuticals
CNTA
$2.25B
| $43.2M | 3.78% | 4,780,560 +1,778,515 | +59% | +$16.1M |
|
|
10
Natera
NTRA
$23.1B
| $40M | 3.5% | 369,068 -287,640 | -44% | -$31.1M |
|
11
Ultragenyx Pharmaceutical
RARE
$2.89B
| $39.6M | 3.47% | 963,146 +172,700 | +22% | +$7.1M |
|
|
12
LivaNova
LIVN
$3.08B
| $38.9M | 3.41% | 710,390 +607,598 | +591% | +$33.3M |
|
13
Insmed
INSM
$28.8B
| $36.9M | 3.24% | 551,303 +268,537 | +95% | +$18M |
|
14
Pliant Therapeutics
PLRX
$101M
| $36.6M | 3.21% | 3,401,213 -133,780 | -4% | -$1.44M |
|
|
15
Vera Therapeutics
VERA
$1.38B
| $36.4M | 3.19% | 1,005,723 +569,590 | +131% | +$20.6M |
|
16
SI-BONE Inc
SIBN
$719M
| $32M | 2.8% | 2,473,289 +124 | +0% | +$1.6K |
|
|
RCM
17
DELISTED
R1 RCM Inc. Common Stock
RCM
| $31M | 2.71% | 2,464,809 -87,516 | -3% | -$1.1M |
|
|
PHLT
18
Performant Healthcare, Inc. Common Stock
PHLT
$603M
| $30.5M | 2.67% | 10,514,200 -927 | -0% | -$2.69K |
|
19
Oscar Health
OSCR
$4.31B
| $29.5M | 2.59% | 1,865,922 -236,632 | -11% | -$3.74M |
|
20
Tandem Diabetes Care
TNDM
$845M
| $28.5M | 2.5% | 708,482 +233,405 | +49% | +$9.4M |
|
|
BCYC
21
Bicycle Therapeutics
BCYC
$511M
| $28M | 2.46% | 1,384,768 +191,717 | +16% | +$3.88M |
|
|
22
Evolent Health
EVH
$1.12B
| $27.6M | 2.42% | 1,445,305 +1,157,124 | +402% | +$22.1M |
|
|
23
Health Catalyst
HCAT
$239M
| $25.3M | 2.22% | 3,956,089 +3,221,408 | +438% | +$20.6M |
|
24
Axogen
AXGN
$743M
| $24.2M | 2.12% | 3,344,033 +2,578,147 | +337% | +$18.7M |
|
25
Structure Therapeutics
GPCR
$1.11B
| $23.2M | 2.03% | 590,647 +441,534 | +296% | +$17.3M |
|